 | • レポートコード：GIR-2104Z14506 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、非感染性髄膜炎ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非感染性髄膜炎ワクチンの種類別市場規模（多糖類ワクチン、複合ワクチン、組み合わせワクチン、髄膜炎菌Bワクチン）、用途別市場規模（髄膜炎、敗血症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・非感染性髄膜炎ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Serum Institute、Sanofi SA、Pfizer、Nuron Biotech、JN-International Medical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：多糖類ワクチン、複合ワクチン、組み合わせワクチン、髄膜炎菌Bワクチン ・用途別分析2016年-2026年：髄膜炎、敗血症、その他 ・非感染性髄膜炎ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・非感染性髄膜炎ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・非感染性髄膜炎ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・非感染性髄膜炎ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・非感染性髄膜炎ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vaccine for Non-infectious Meningitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vaccine for Non-infectious Meningitis size is estimated to be xx million in 2020 from USD 1 million in 2019, with a change of XX% between 2019 and 2020. The global Vaccine for Non-infectious Meningitis market size is expected to grow at a CAGR of 11.5% for the next five years.
Market segmentation
Vaccine for Non-infectious Meningitis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines
Market segment by Application can be divided into
Meningitis
Septicemia
Others
The key market players for global Vaccine for Non-infectious Meningitis market are listed below:
Serum Institute
Sanofi SA
Pfizer
Nuron Biotech
JN-International Medical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Vaccine for Non-infectious Meningitis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Global Vaccine for Non-infectious Meningitis Market Size & Forecast
1.4.1 Global Vaccine for Non-infectious Meningitis Sales in Value (2016-2026))
1.4.2 Global Vaccine for Non-infectious Meningitis Sales in Volume (2016-2026)
1.4.3 Global Vaccine for Non-infectious Meningitis Price by Type (2016-2026) & (USD/Unit)
1.5 Global Vaccine for Non-infectious Meningitis Production Capacity Analysis
1.5.1 Global Vaccine for Non-infectious Meningitis Total Production Capacity (2016-2026)
1.5.2 Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine for Non-infectious Meningitis Market Drivers
1.6.2 Vaccine for Non-infectious Meningitis Market Restraints
1.6.3 Vaccine for Non-infectious Meningitis Trends Analysis
2 Manufacturers Profiles
2.1 Serum Institute
2.1.1 Serum Institute Details
2.1.2 Serum Institute Major Business
2.1.3 Serum Institute Vaccine for Non-infectious Meningitis Product and Services
2.1.4 Serum Institute Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi SA
2.2.1 Sanofi SA Details
2.2.2 Sanofi SA Major Business
2.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
2.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Vaccine for Non-infectious Meningitis Product and Services
2.3.4 Pfizer Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Nuron Biotech
2.4.1 Nuron Biotech Details
2.4.2 Nuron Biotech Major Business
2.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
2.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 JN-International Medical
2.5.1 JN-International Medical Details
2.5.2 JN-International Medical Major Business
2.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
2.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Vaccine for Non-infectious Meningitis Sales by Manufacturer
3.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vaccine for Non-infectious Meningitis
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccine for Non-infectious Meningitis Manufacturer Market Share
3.4.2 Top 6 Vaccine for Non-infectious Meningitis Manufacturer Market Share
3.5 Global Vaccine for Non-infectious Meningitis Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vaccine for Non-infectious Meningitis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vaccine for Non-infectious Meningitis Market Size by Region
4.1.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Region (2016-2026)
4.1.2 Global Vaccine for Non-infectious Meningitis Revenue by Region (2016-2026)
4.2 North America Vaccine for Non-infectious Meningitis Revenue (2016-2026)
4.3 Europe Vaccine for Non-infectious Meningitis Revenue (2016-2026)
4.4 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2016-2026)
4.5 South America Vaccine for Non-infectious Meningitis Revenue (2016-2026)
4.6 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Type (2016-2026)
5.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2016-2026)
5.3 Global Vaccine for Non-infectious Meningitis Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Application (2016-2026)
6.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2016-2026)
6.3 Global Vaccine for Non-infectious Meningitis Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vaccine for Non-infectious Meningitis Sales by Type (2016-2026)
7.2 North America Vaccine for Non-infectious Meningitis Sales by Application (2016-2026)
7.3 North America Vaccine for Non-infectious Meningitis Market Size by Country
7.3.1 North America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2016-2026)
7.3.2 North America Vaccine for Non-infectious Meningitis Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vaccine for Non-infectious Meningitis Sales by Type (2016-2026)
8.2 Europe Vaccine for Non-infectious Meningitis Sales by Application (2016-2026)
8.3 Europe Vaccine for Non-infectious Meningitis Market Size by Country
8.3.1 Europe Vaccine for Non-infectious Meningitis Sales in Volume by Country (2016-2026)
8.3.2 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2016-2026)
9.2 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2016-2026)
9.3 Asia-Pacific Vaccine for Non-infectious Meningitis Market Size by Region
9.3.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vaccine for Non-infectious Meningitis Sales by Type (2016-2026)
10.2 South America Vaccine for Non-infectious Meningitis Sales by Application (2016-2026)
10.3 South America Vaccine for Non-infectious Meningitis Market Size by Country
10.3.1 South America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2016-2026)
10.3.2 South America Vaccine for Non-infectious Meningitis Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2016-2026)
11.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2016-2026)
11.3 Middle East & Africa Vaccine for Non-infectious Meningitis Market Size by Country
11.3.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vaccine for Non-infectious Meningitis Typical Distributors
12.3 Vaccine for Non-infectious Meningitis Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vaccine for Non-infectious Meningitis Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vaccine for Non-infectious Meningitis Revenue by Application, (USD Million), 2021-2026
Table 3. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute Major Business
Table 5. Serum Institute Vaccine for Non-infectious Meningitis Product and Services
Table 6. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi SA Major Business
Table 9. Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
Table 10. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Vaccine for Non-infectious Meningitis Product and Services
Table 14. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nuron Biotech Basic Information, Manufacturing Base and Competitors
Table 16. Nuron Biotech Major Business
Table 17. Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
Table 18. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. JN-International Medical Basic Information, Manufacturing Base and Competitors
Table 20. JN-International Medical Major Business
Table 21. JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
Table 22. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Vaccine for Non-infectious Meningitis Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Vaccine for Non-infectious Meningitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Vaccine for Non-infectious Meningitis Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Vaccine for Non-infectious Meningitis Production Site of Key Manufacturer
Table 28. Global Vaccine for Non-infectious Meningitis Sales by Region (2016-2021e) & (K Units)
Table 29. Global Vaccine for Non-infectious Meningitis Sales by Region (2021-2026) & (K Units)
Table 30. Global Vaccine for Non-infectious Meningitis Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Vaccine for Non-infectious Meningitis Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 33. Global Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 34. Global Vaccine for Non-infectious Meningitis Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Vaccine for Non-infectious Meningitis Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Vaccine for Non-infectious Meningitis Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Vaccine for Non-infectious Meningitis Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 39. Global Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 40. Global Vaccine for Non-infectious Meningitis Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Vaccine for Non-infectious Meningitis Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Vaccine for Non-infectious Meningitis Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Vaccine for Non-infectious Meningitis Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Vaccine for Non-infectious Meningitis Sales by Country (2016-2021e) & (K Units)
Table 45. North America Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (K Units)
Table 46. North America Vaccine for Non-infectious Meningitis Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Vaccine for Non-infectious Meningitis Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 49. North America Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 50. North America Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 51. North America Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 52. Europe Vaccine for Non-infectious Meningitis Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (K Units)
Table 54. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 58. Europe Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 68. South America Vaccine for Non-infectious Meningitis Sales by Country (2016-2021e) & (K Units)
Table 69. South America Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (K Units)
Table 70. South America Vaccine for Non-infectious Meningitis Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Vaccine for Non-infectious Meningitis Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 73. South America Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 74. South America Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 75. South America Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Vaccine for Non-infectious Meningitis Typical Distributors
Table 87. Vaccine for Non-infectious Meningitis Typical Customers
List of Figures
Figure 1. Vaccine for Non-infectious Meningitis Picture
Figure 2. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type in 2020
Figure 3. Polysaccharide Vaccines
Figure 4. Conjugate Vaccines
Figure 5. Combination Vaccines
Figure 6. Men B Vaccines
Figure 7. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application in 2020
Figure 8. Meningitis
Figure 9. Septicemia
Figure 10. Others
Figure 11. Global Vaccine for Non-infectious Meningitis Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Vaccine for Non-infectious Meningitis Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Vaccine for Non-infectious Meningitis Sales (2016-2026) & (K Units)
Figure 33. Global Vaccine for Non-infectious Meningitis Production Capacity (2016-2026) & (K Units)
Figure 34. Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Vaccine for Non-infectious Meningitis Market Drivers
Figure 36. Vaccine for Non-infectious Meningitis Market Restraints
Figure 37. Vaccine for Non-infectious Meningitis Market Trends
Figure 38. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturer in 2020
Figure 39. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturer in 2020
Figure 40. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2016-2026)
Figure 44. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2016-2026)
Figure 45. North America Vaccine for Non-infectious Meningitis Revenue (2016-2026) & (USD Million)
Figure 46. Europe Vaccine for Non-infectious Meningitis Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2016-2026) & (USD Million)
Figure 48. South America Vaccine for Non-infectious Meningitis Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue (2016-2026) & (USD Million)
Figure 50. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2016-2026)
Figure 51. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2016-2026)
Figure 52. Global Vaccine for Non-infectious Meningitis Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 54. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2016-2026)
Figure 55. Global Vaccine for Non-infectious Meningitis Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2016-2026)
Figure 57. North America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2016-2026)
Figure 58. North America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2016-2026)
Figure 59. North America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 60. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2016-2026)
Figure 61. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2016-2026)
Figure 62. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Type (2016-2026)
Figure 63. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 68. South America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2016-2026)
Figure 69. South America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2016-2026)
Figure 70. South America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2016-2026)
Figure 71. South America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…- 世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- 世界の髄膜炎診断検査市場規模・現状・予測（2021年-2027年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …
- 世界のワクチン＆ワクチン接種市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines & Vaccination Market The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…